View
220
Download
1
Embed Size (px)
Citation preview
Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing
1. Congresswoman Donna M. Christensen, M.D.
Chair, Congressional Black Caucus [CBC]
1. Congresswoman Donna M. Christensen, M.D.
Chair, Congressional Black Caucus [CBC]
Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005
Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing
2. Gary A. Puckrein, Ph.D.National Minority Health Month Foundation
2. Gary A. Puckrein, Ph.D.National Minority Health Month Foundation
Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005
Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing
3. B. Waine Kong, J.D., Ph.D.CEO – American Association of Black Cardiologists [ABC]
3. B. Waine Kong, J.D., Ph.D.CEO – American Association of Black Cardiologists [ABC]
Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005
Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing
4. Debra Lee
4. Debra Lee
Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005
Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing
5. Shomarka Omar Y. Keita, M.D., D.Phil.Medical Officer - Department of Human Services, District of ColumbiaResearch Associate - Anthropology Department, Smithsonian Institution
5. Shomarka Omar Y. Keita, M.D., D.Phil.Medical Officer - Department of Human Services, District of ColumbiaResearch Associate - Anthropology Department, Smithsonian Institution
Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005
Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing
6. Jonathan Kahn, J.D., Ph.D.Assistant ProfessorHamline University School of Law
6. Jonathan Kahn, J.D., Ph.D.Assistant ProfessorHamline University School of Law
Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005
Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing
7. Charles L. Curry, M.D., FACC, FACPPresident - International Society on Hypertension in Blacks
7. Charles L. Curry, M.D., FACC, FACPPresident - International Society on Hypertension in Blacks
Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005
Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing
8. Basil Halliday, M.Sc.
President & CEO - BDH Clinical Research Services
8. Basil Halliday, M.Sc.
President & CEO - BDH Clinical Research Services
Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005
Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing
9. Charles N. Rotimi, Ph.D.National Human Genome Center Howard University
9. Charles N. Rotimi, Ph.D.National Human Genome Center Howard University
Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005
Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing
10. Charmaine Royal, Ph.D.
National Human Genome CenterHoward University
10. Charmaine Royal, Ph.D.
National Human Genome CenterHoward University
Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005
Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing
11. Olivia Carter-Pokras, Ph.D.Associate Professor – University of Maryland, School of Medicine, Dept. of Epidemiology
11. Olivia Carter-Pokras, Ph.D.Associate Professor – University of Maryland, School of Medicine, Dept. of Epidemiology
Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005
Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing
12. Lucille C. Norville Perez, MDNational Health Director - National Associationfor the Advancement of Colored People
12. Lucille C. Norville Perez, MDNational Health Director - National Associationfor the Advancement of Colored People
Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005
Open Public Hearing Open Public Hearing Open Public Hearing Open Public Hearing
13. Dianna Wells13. Dianna Wells
Cardiovascular and Renal Drugs Advisory CommitteeCardiovascular and Renal Drugs Advisory CommitteeJune 16, 2005June 16, 2005